Flugen Inc.
Madison, WI Doing business as Flugen Inc.
- UEI
- M9FHAR3RBML5
- CAGE
- 54YS4
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 597 Science Dr, Madison, WI 53711, USA
- Website
- flugen.com
- Founded
- 2007
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| The overall objective of this contract is to identify humoral correlates of protection following H3N2 M2SR… | Office of the Assistant Secretary for Preparedness and Response | $741,722 | |
| Optimization of downstream recovery and stabilization of drug substance of an intranasal influenza vaccine | Defense Health Agency | $6,237,445 | |
| Scalable manufacturing and toxicity testing of intranasal M2SR influenza vaccine | Defense Health Agency | $5,599,997 | |
| Safety and immunogenicity of H3N2 M2SR monovalent influenza vaccine administered with inactivated flu vaccine in older… | Defense Health Agency | $11,439,843 | |
| Safety and immunogenicity of H3N2 M2SR monovalent influenza vaccine in older subjects | National Institute of Allergy and Infectious Diseases | $7,823,420 |
About Flugen Inc.
Flugen Inc. is a biopharmaceutical company based in Madison, Wisconsin, specializing in the development of innovative intranasal influenza vaccine technologies. As a for-profit organization registered in SAM.gov, the company focuses on advancing vaccine research and development, with a particular emphasis on creating novel approaches to influenza prevention. The company provides specialized biomedical research services to federal agencies, primarily targeting vaccine development and medical research solutions.
The company's federal contract work is currently focused on a specific research project awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR). This $741,722.15 firm-fixed-price definitive contract, awarded on July 25, 2025, aims to identify humoral correlates of protection following H3N2 M2SR vaccination. The contract's primary objective is to support clinical development of an M2SR strategy that can induce both seasonal influenza immunity and pre-pandemic protection. The contract does not utilize any specific set-aside designation and is scheduled for completion by February 28, 2027.
Flugen Inc. has been particularly active in federal grant awards, primarily through the Defense Health Agency's Military Medical Research and Development program. The company has received multiple project grants totaling over $11.8 million, focusing on intranasal influenza vaccine research. These grants support critical research initiatives, including optimizing downstream recovery and stabilization of vaccine drug substances, developing scalable manufacturing methods, conducting toxicity testing, and investigating the safety and immunogenicity of H3N2 M2SR monovalent influenza vaccines. The grant work spans multiple years, with current projects running through March 31, 2027, and aims to advance vaccine technology that could potentially benefit military personnel and broader public health populations.
Quick answers
What is Flugen Inc.'s UEI?
Flugen Inc.'s Unique Entity ID (UEI) in SAM.gov is M9FHAR3RBML5.
What is Flugen Inc.'s CAGE code?
Flugen Inc.'s CAGE code is 54YS4.
What is Flugen Inc.'s primary NAICS code?
Flugen Inc.'s primary NAICS code is 325414 (Biological Product (except Diagnostic) Manufacturing).
Where is Flugen Inc. located?
Flugen Inc.'s physical address in SAM.gov is 597 Science Dr, Madison, WI 53711, USA.
Is Flugen Inc. registered in SAM.gov?
Yes. Flugen Inc.'s SAM.gov registration is active through November 12, 2026.
What is Flugen Inc.'s most recent federal award?
Flugen Inc.'s most recent federal contract award is The overall objective of this contract is to identify humoral correlates of protection following H3N2 M2SR… (75A50125C00005), from Office of the Assistant Secretary for Preparedness and Response, on July 25, 2025.
On GovTribe
See Flugen Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors